share_log

Needham Reiterates Buy on Taysha Gene Therapies, Maintains $7 Price Target

Moomoo 24/7 ·  Apr 11 06:26

Needham analyst Gil Blum reiterates Taysha Gene Therapies (NASDAQ:TSHA) with a Buy and maintains $7 price target.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment